ArticleBMC surgery2025
Robot-assisted ureteral reimplantation using the KangDuo surgical Robot-01 system: a prospective, single-center, single-arm pilot study.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundUreteral reimplantation plays a crucial role in distal ureteral reconstruction, and the integration of robotic systems has greatly enhanced minimally invasive surgical techniques. This pilot study aims to evaluate the technically feasibility and safety of the newly developed KangDuo Surgical Robot-01 (KD-SR-01) system in performing robot-assisted ureteral reimplantation.
methodsThis prospective, single-center, single-arm pilot study was conducted from February 2022 to June 2024. Thirty-one ureteral reimplantation procedures were performed using the KD-SR-01 system. We collected the patients' characteristics, perioperative data and follow-up findings prospectively. We used the NASA-TLX (National Aeronautics and Space Administration Task Load Index) to assess ergonomics.
resultsAll 31 procedures were completed successfully without conversion. The median operative time was 153 min (IQR, 136-178.5 min). The median estimated blood loss was 20 mL (IQR, 15-35 mL). No patients needed blood transfusions during the operation. No severe complications occurred either intraoperatively or postoperatively. The median postoperative hospital stay was 4 days (IQR, 4-4 days). At a median follow-up of 22 months (IQR, 13-35 months), the subjective success rate was 96.8% (95% confidence interval: 83.3-99.9%). The surgeon indicated a high level of comfort, with a NASA-TLX global score of 9.47 ± 4.97.
conclusionsThe KD-SR-01 system is technically feasible and safe for robot-assisted ureteral reimplantation.
trial registrationThis study was registered at www.chictr.org.cn (ChiCTR2200056553) on February 7, 2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.